Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.15% |
| 2 | Technology | 16.1% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Verisk Analytics
VRSK
$23.7B
| $2.3M | ﹤0.01% |
27,607
-359,093
| -93% | -$29.8M |
|
|
DL
2227
DELISTED
China Distance Education Holdings Limited
DL
| $2.3M | ﹤0.01% |
342,200
-13,800
| -4% | -$101K |
|
2228
Kewaunee Scientific
KEQU
$105M
| $2.29M | ﹤0.01% |
77,800
+13,900
| +22% | +$365K |
|
2229
Grupo SIMEC
SIM
$4.68B
| $2.29M | ﹤0.01% |
222,900
-9,400
| -4% | -$101K |
|
|
PVLA
2230
Palvella Therapeutics
PVLA
$2.25B
| $2.29M | ﹤0.01% |
4,964
+3,515
| +243% | +$1.5M |
|
2231
M/I Homes
MHO
$3.87B
| $2.28M | ﹤0.01% |
85,409
-174,491
| -67% | -$4.52M |
|
2232
Xencor
XNCR
$1.7B
| $2.28M | ﹤0.01% |
+99,600
| New | +$2.21M |
|
|
TTPH
2233
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.28M | ﹤0.01% |
16,679
+9,495
| +132% | +$1.27M |
|
2234
CEMIG Preferred Shares
CIG
$5.49B
| $2.27M | ﹤0.01% |
1,797,920
-44,140
| -2% | -$60.2K |
|
2235
TAT Technologies
TATT
$532M
| $2.27M | ﹤0.01% |
202,900
+20,700
| +11% | +$221K |
|
2236
Harvard Bioscience
HBIO
$30.5M
| $2.27M | ﹤0.01% |
60,505
+1,505
| +3% | +$44.5K |
|
2237
IRIDEX
IRIX
$15M
| $2.27M | ﹤0.01% |
241,900
-1,100
| -0.5% | -$10K |
|
|
KEYW
2238
DELISTED
The KEYW Holding Corporation
KEYW
| $2.26M | ﹤0.01% |
296,500
+259,400
| +699% | +$2.1M |
|
|
TCF
2239
DELISTED
TCF Financial Corporation Common Stock
TCF
| $2.25M | ﹤0.01% |
43,047
-27,228
| -39% | -$1.3M |
|
|
FFG
2240
DELISTED
FBL Financial Group
FFG
| $2.25M | ﹤0.01% |
30,155
-34,845
| -54% | -$2.39M |
|
2241
Chegg
CHGG
$88.5M
| $2.25M | ﹤0.01% |
151,362
-818,038
| -84% | -$11.7M |
|
|
USAP
2242
DELISTED
Universal Stainless & Alloy
USAP
| $2.24M | ﹤0.01% |
107,626
+31,126
| +41% | +$594K |
|
2243
Wolfspeed
WOLF
$1.6B
| $2.24M | ﹤0.01% |
+79,542
| New | +$1.98M |
|
2244
Cumberland Pharmaceuticals
CPIX
$117M
| $2.23M | ﹤0.01% |
316,005
+25,152
| +9% | +$174K |
|
|
ICAD
2245
DELISTED
iCAD Inc
ICAD
| $2.23M | ﹤0.01% |
503,760
+13,600
| +3% | +$52.1K |
|
2246
NN Inc
NNBR
$325M
| $2.22M | ﹤0.01% |
+76,686
| New | +$2.08M |
|
|
VSI
2247
DELISTED
Vitamin Shoppe Inc.
VSI
| $2.22M | ﹤0.01% |
415,400
+335,099
| +417% | +$2.59M |
|
|
TST
2248
DELISTED
TheStreet, Inc.
TST
| $2.22M | ﹤0.01% |
205,480
+11,359
| +6% | +$98.8K |
|
2249
Greif Class B
GEF.B
$4.16B
| $2.22M | ﹤0.01% |
34,500
-600
| -2% | -$36.6K |
|
2250
Alico
ALCO
$303M
| $2.21M | ﹤0.01% |
64,744
+7,153
| +12% | +$227K |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.